Aquamin® as an Adjuvant Intervention for Ulcerative Colitis
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Aquamin® works as a potential treatment to
improve symptoms and if it will induce remission in patients with mild Ulcerative Colitis and
extend remission in Ulcerative Colitis in remission.